Lecanemab

  • Biologic
  • LEQEMBI

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Lecanemab: storage and handling

Refrigerate
Yes, as the label states
Label statement
Intravenous Infusion Unopened Vial Store LEQEMBI vials in a refrigerator at 2°C to 8°C (36°F to 46°F).
Freezing
Do not freeze
Label statement
Do not freeze or shake.
Room temperature
up to 14 days at or below 25°C (77°F)
Label statement
If needed, the autoinjectors can be stored at room temperature up to 25°C (77°F) in the original carton for up to 14 days.
Room temperature
up to 14 days at or below 25°C (77°F)
Label statement
LEQEMBI IQLIK may be stored at room temperature up to 77°F (25°C) for up to 14 days in the original carton.
Back into the refrigerator
Not allowed
Label statement
Once the autoinjector has been stored at room temperature, do not return it to the refrigerator.
Light
Protect from light
Label statement
Store in the original carton to protect from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 14 days at up to 25°C (77°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

If needed, the autoinjectors can be stored at room temperature up to 25°C (77°F) in the original carton for up to 14 days.
Once the autoinjector has been stored at room temperature, do not return it to the refrigerator.
Discard the autoinjector(s) if these conditions are exceeded.
Throw away (dispose of) LEQEMBI IQLIK that is out of date, or if it is not stored the right way.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-888-274-2378 (the number printed on the label) about this product.

Where the label prints this number
and Biogen For more information, go to www.LEQEMBI.com or call 1-888-274-2378.
All storage statements on the label (17)
  • Intravenous Infusion Unopened Vial Store LEQEMBI vials in a refrigerator at 2°C to 8°C (36°F to 46°F).
  • Store in the original carton to protect from light.
  • Do not freeze or shake.
  • Subcutaneous Injection Store LEQEMBI IQLIK autoinjectors in a refrigerator at 2°C to 8°C (36°F to 46°F).
  • Store in original carton to protect from light.
  • Do not freeze.
  • If needed, the autoinjectors can be stored at room temperature up to 25°C (77°F) in the original carton for up to 14 days.
  • Once the autoinjector has been stored at room temperature, do not return it to the refrigerator.
  • Discard the autoinjector(s) if these conditions are exceeded.
  • Storing LEQEMBI IQLIK Store the LEQEMBI IQLIK autoinjector in a refrigerator between 36˚F to 46˚F (2˚C to 8°C).
  • Keep the LEQEMBI IQLIK autoinjector in the original carton until ready to use, to protect it from light.
  • LEQEMBI IQLIK may be stored at room temperature up to 77°F (25°C) for up to 14 days in the original carton.
  • Do not place it back in the refrigerator if it has been brought to room temperature.
  • Throw away (dispose of) LEQEMBI IQLIK that is out of date, or if it is not stored the right way.
  • The LEQEMBI IQLIK 360 mg autoinjector Gather Supplies Preparing to Inject LEQEMBI IQLIK Step 1 Remove carton from the refrigerator and wait 20 minutes for the autoinjector to reach room temperature.
  • Do not try to speed up the warming process in any way because the product may be damaged.
  • Do not use if the expiration date on the carton has passed.

FDA label version 24, effective July 21, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.